SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-11-000636
Filing Date
2011-03-03
Accepted
2011-03-03 14:56:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 K-V PHARMACEUTICAL COMPANY p11-0613sc13da.htm SC 13D/A 214227
  Complete submission text file 0000902664-11-000636.txt   215687
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-12338 | Film No.: 11659793
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PARK AVENUE, 12TH FLOOR NEW YORK NY 10152
Business Address 375 PARK AVENUE, 12TH FLOOR NEW YORK NY 10152 212 672 5000
Centerbridge Partners, L.P. (Filed by) CIK: 0001484836 (see all company filings)

IRS No.: 204920398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A